Pyxis Oncology is trading 10.17% down at $3.09 after falling from the September 1, 2026 close of $3.44; no clear company-specific negative announcement or overnight earnings catalyst was identified.
- Latest company news was a September 1 conference-participation announcement; its investor-relations page showed no newer release as of September 2.
- Broader risk-off sentiment and weaker Nasdaq futures may be contributing, but the move is not directly explained.